Identification and treatment of bronchoconstriction induced by a vagus nerve stimulator employed for management of seizure disorder

Chest

Volumn 127, Issue 1, 2005, Pages 401-402

  Bijwadia, Jagdeep S ^a,b   Hoch, Robert C ^a   Dexter, Donn D ^a  

^a Luther Midelfort Mayo Health System   (United States)

^b REGIONS HOSPITAL   (United States)

Author keywords

Bronchoconstriction; Dyspnea; Seizure; Vagus nerve stimulator

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHOSPASM; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; PRIORITY JOURNAL; SEIZURE; SPIROMETRY; VAGUS NERVE STIMULATION; DYSPNEA; ELECTRODE; ELECTROSTIMULATION THERAPY; EQUIPMENT; INSTRUMENTATION; MIDDLE AGED; VAGUS NERVE;

BRONCHOCONSTRICTION; DYSPNEA; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; FEMALE; HUMANS; MIDDLE AGED; SEIZURES; SPIROMETRY; VAGUS NERVE;

EID: 13844315726     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.1.401     Document Type: Article

References (5)

1. McLachlan RS. Vagus nerve stimulation for intractable epilepsy: a review. J Clin Neurophysiol 1997; 14:358-368
2. Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 2001; 18:415-418
3. Schacter S. Vagus nerve stimulation therapy summary: five years after FDA approval. Neurology 2002; 59(suppl):S15-S20
4. Coleridge JCG, Coleridge HM. Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol 1984; 99:2-110
5. Krishnakumar S, Holmes EP, Moore RM, et al. Non-adrenergic non-cholinergic excitatory innervation in the airways: role of neurokinin-2 receptors. Auton Autacoid Pharmacol 2002; 22:215-224